Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-22-000037

Chief Operating Officer acquired 23,607 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Miller Matthew P Chief Operating Officer 2022-11-17 Grant or award +23,607 101,641 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Miller Matthew P Chief Operating Officer 2022-11-17 Grant or award · Non-Qualified Stock Option (right to buy) +119,825 119,825 D: show line 2 in the form
Loading xslF345X03/edgardoc.xml…